<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
	<url>
		<loc>https://financereviewdaily.com/en/article/finma-restructures-ubs-oversight-department-ahead-of-2027</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-10-01T11:00:00+00:00</news:publication_date>
			<news:title>Finma Restructures UBS Oversight Department Ahead of 2027</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/de/article/finma-restructures-ubs-oversight-department-ahead-of-2027</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>de</news:language>
			</news:publication>
			<news:publication_date>2026-10-01T11:00:00+00:00</news:publication_date>
			<news:title>Finma stellt Aufsichtsbereich für UBS im Hinblick auf 2027 neu auf</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/fr/article/finma-restructures-ubs-oversight-department-ahead-of-2027</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>fr</news:language>
			</news:publication>
			<news:publication_date>2026-10-01T11:00:00+00:00</news:publication_date>
			<news:title>La Finma réorganise le département de surveillance d&apos;UBS en vue de 2027</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/en/article/sandoz-launches-high-volume-biosimilar-drug-substance-plant</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-10-01T06:00:00+00:00</news:publication_date>
			<news:title>Sandoz launches high‑volume biosimilar drug substance plant in Slovenia</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/de/article/sandoz-launches-high-volume-biosimilar-drug-substance-plant</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>de</news:language>
			</news:publication>
			<news:publication_date>2026-10-01T06:00:00+00:00</news:publication_date>
			<news:title>Sandoz nimmt Grossanlage für Biosimilars in Slowenien in Betrieb</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/fr/article/sandoz-launches-high-volume-biosimilar-drug-substance-plant</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>fr</news:language>
			</news:publication>
			<news:publication_date>2026-10-01T06:00:00+00:00</news:publication_date>
			<news:title>Sandoz inaugure une usine de substances médicamenteuses biosimilaires à grand volume en Slovénie</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/en/article/dax-closes-lower-inflation-concerns-offset-positive-us-data</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-10-01T06:00:00+00:00</news:publication_date>
			<news:title>DAX Closes Lower as Inflation Concerns Offset Positive US Data</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/de/article/dax-closes-lower-inflation-concerns-offset-positive-us-data</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>de</news:language>
			</news:publication>
			<news:publication_date>2026-10-01T06:00:00+00:00</news:publication_date>
			<news:title>DAX schliesst tiefer – Inflationssorgen dämpfen positive US-Daten</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/fr/article/dax-closes-lower-inflation-concerns-offset-positive-us-data</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>fr</news:language>
			</news:publication>
			<news:publication_date>2026-10-01T06:00:00+00:00</news:publication_date>
			<news:title>Le DAX clôture en baisse, les craintes sur l&apos;inflation éclipsant les bons chiffres américains</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/en/article/dubai-based-jupiter-wealth-opens-geneva-office-appoints</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-10-01T06:00:00+00:00</news:publication_date>
			<news:title>Dubai‑based Jupiter Wealth opens Geneva office, appoints Diego Wuergler as Head of Switzerland and CIO</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/de/article/dubai-based-jupiter-wealth-opens-geneva-office-appoints</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>de</news:language>
			</news:publication>
			<news:publication_date>2026-10-01T06:00:00+00:00</news:publication_date>
			<news:title>Jupiter Wealth mit Sitz in Dubai eröffnet Büro in Zürich und ernennt Diego Wuergler zum Schweiz-Chef und CIO</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/fr/article/dubai-based-jupiter-wealth-opens-geneva-office-appoints</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>fr</news:language>
			</news:publication>
			<news:publication_date>2026-10-01T06:00:00+00:00</news:publication_date>
			<news:title>Jupiter Wealth, basé à Dubaï, ouvre un bureau à Genève et nomme Diego Wuergler à la tête de la Suisse et de la direction des investissements</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/en/article/snb-holds-policy-rate-0-pct-inflation-eases-gdp-growth-stays</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T16:00:00+00:00</news:publication_date>
			<news:title>SNB holds policy rate at 0% as inflation eases and GDP growth stays strong</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/de/article/snb-holds-policy-rate-0-pct-inflation-eases-gdp-growth-stays</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>de</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T16:00:00+00:00</news:publication_date>
			<news:title>SNB belässt Leitzins bei 0% – Teuerung schwächt sich ab und BIP-Wachstum bleibt stark</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/fr/article/snb-holds-policy-rate-0-pct-inflation-eases-gdp-growth-stays</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>fr</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T16:00:00+00:00</news:publication_date>
			<news:title>La BNS maintient son taux directeur à 0% dans un contexte de détente de l&apos;inflation et de croissance robuste du PIB</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/en/article/bmw-unveils-major-restructuring-targets-8-10-pct-roe-early</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T16:00:00+00:00</news:publication_date>
			<news:title>BMW Unveils Major Restructuring, Targets 8-10% ROE by Early 2030s</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/de/article/bmw-unveils-major-restructuring-targets-8-10-pct-roe-early</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>de</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T16:00:00+00:00</news:publication_date>
			<news:title>BMW kündigt umfassende Umstrukturierung an, strebt 8-10 % ROE ab Anfang 2030er an</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/fr/article/bmw-unveils-major-restructuring-targets-8-10-pct-roe-early</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>fr</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T16:00:00+00:00</news:publication_date>
			<news:title>BMW dévoile une restructuration d&apos;envergure et vise un ROE de 8-10% au début des années 2030</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/en/article/swiss-analysts-anticipate-higher-inflation-rates-while</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T16:00:00+00:00</news:publication_date>
			<news:title>Swiss analysts anticipate higher inflation and rates while keeping growth outlook positive</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/de/article/swiss-analysts-anticipate-higher-inflation-rates-while</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>de</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T16:00:00+00:00</news:publication_date>
			<news:title>Schweizer Analysten erwarten höhere Inflation und Zinsen bei weiterhin positiven Wachstumsaussichten</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/fr/article/swiss-analysts-anticipate-higher-inflation-rates-while</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>fr</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T16:00:00+00:00</news:publication_date>
			<news:title>Les analystes suisses prévoient une hausse de l&apos;inflation et des taux tout en maintenant un optimisme sur la croissance</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/en/article/byd-aims-top-three-swiss-market-sales-reach-4-2-pct-share</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T16:00:00+00:00</news:publication_date>
			<news:title>BYD aims for top three in Swiss market as sales reach 4.2% share</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/de/article/byd-aims-top-three-swiss-market-sales-reach-4-2-pct-share</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>de</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T16:00:00+00:00</news:publication_date>
			<news:title>BYD strebt Top‑Drei‑Platzierung im Schweizer Markt an bei 4,2 % Marktanteil</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/fr/article/byd-aims-top-three-swiss-market-sales-reach-4-2-pct-share</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>fr</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T16:00:00+00:00</news:publication_date>
			<news:title>BYD vise le top trois sur le marché suisse avec une part de marché de 4,2%</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/en/article/jpmorgan-buys-into-struggling-swiss-biotech-kuros-despite-34</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T16:00:00+00:00</news:publication_date>
			<news:title>JPMorgan Buys Into Struggling Swiss Biotech Kuros Despite 34% Year-to-Date Slide</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/de/article/jpmorgan-buys-into-struggling-swiss-biotech-kuros-despite-34</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>de</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T16:00:00+00:00</news:publication_date>
			<news:title>JPMorgan steigt trotz 34 Prozent Kursverlust seit Jahresbeginn bei angeschlagener Schweizer Biotechfirma Kuros ein</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/fr/article/jpmorgan-buys-into-struggling-swiss-biotech-kuros-despite-34</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>fr</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T16:00:00+00:00</news:publication_date>
			<news:title>JPMorgan entre au capital de la biotech suisse en difficulté Kuros en dépit d&apos;une chute de 34% depuis le début de l&apos;année</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/en/article/eurostoxx-50-climbs-0-3-pct-investors-stay-upbeat-oil-bond</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T06:00:00+00:00</news:publication_date>
			<news:title>EuroStoxx 50 climbs 0.3% as investors stay upbeat amid oil and bond yields</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/de/article/eurostoxx-50-climbs-0-3-pct-investors-stay-upbeat-oil-bond</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>de</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T06:00:00+00:00</news:publication_date>
			<news:title>EuroStoxx 50 steigt um 0,3 % bei anhaltender Investorenzuversicht angesichts Öl- und Anleiherenditen</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/fr/article/eurostoxx-50-climbs-0-3-pct-investors-stay-upbeat-oil-bond</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>fr</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T06:00:00+00:00</news:publication_date>
			<news:title>L&apos;EuroStoxx 50 progresse de 0,3% alors que les investisseurs restent optimistes malgré le pétrole et les rendements obligataires</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/en/article/docmorris-shares-rise-10-pct-target-raised-redcare-lagging</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T06:00:00+00:00</news:publication_date>
			<news:title>DocMorris shares rise 10% as target raised, Redcare lagging</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/de/article/docmorris-shares-rise-10-pct-target-raised-redcare-lagging</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>de</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T06:00:00+00:00</news:publication_date>
			<news:title>DocMorris-Aktien steigen um 10% nach Kurszielerhöhung, Redcare hinkt hinterher</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/fr/article/docmorris-shares-rise-10-pct-target-raised-redcare-lagging</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>fr</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T06:00:00+00:00</news:publication_date>
			<news:title>L&apos;action DocMorris bondit de 10 % grâce à un objectif relevé, Redcare à la traîne</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/en/article/unicredit-expected-pledge-peaceful-commerzbank-takeover-says</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T06:00:00+00:00</news:publication_date>
			<news:title>UniCredit expected to pledge peaceful Commerzbank takeover, says German government</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/de/article/unicredit-expected-pledge-peaceful-commerzbank-takeover-says</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>de</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T06:00:00+00:00</news:publication_date>
			<news:title>UniCredit wird laut deutscher Regierung voraussichtlich friedliche Commerzbank-Übernahme zusichern</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/fr/article/unicredit-expected-pledge-peaceful-commerzbank-takeover-says</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>fr</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T06:00:00+00:00</news:publication_date>
			<news:title>UniCredit devrait s&apos;engager sur une reprise amicale de Commerzbank, selon le gouvernement allemand</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/en/article/currency-pair-nicknames-explained</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>en</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T05:17:00+00:00</news:publication_date>
			<news:title>Cable, Aussie, and Kiwi: Where Currency Pair Nicknames Come From</news:title>
		</news:news>
	</url>
	<url>
		<loc>https://financereviewdaily.com/fr/article/currency-pair-nicknames-explained</loc>
		<news:news>
			<news:publication>
				<news:name>Finance Review Daily</news:name>
				<news:language>fr</news:language>
			</news:publication>
			<news:publication_date>2026-09-30T05:17:00+00:00</news:publication_date>
			<news:title>Cable, Aussie et Kiwi : d&apos;où viennent les surnoms des paires de devises</news:title>
		</news:news>
	</url>
</urlset>
